Spirox
Company

Last deal

$45M

Amount

Series C

Stage

15.03.2016

Date

3

all rounds

$71.5M

Total amount

date founded

Financing round

General

About Company
Spirox is a California-based medical device company that improves the quality of life for patients with nasal obstruction.

Industry

Sector :

Subsector :

Also Known As

Nasoform

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Series C

IPO status

Private

Description

The company, formerly known as Nasoform, has developed the LATERA absorbable nasal implant to address nasal valve collapse (NVC), a common but undertreated cause of nasal obstruction. The implant provides a minimally invasive option for ENTs and facial plastic surgeons to treat nasal airway obstruction caused by weakened lateral wall cartilage. Founded in 2011, Spirox intends to use funds to complete development, seek US marketing authorization, and initiate product commercialization.
Contacts

Phone number

Social url

Similar Companies
1000
Tympanogen, Inc.

Tympanogen, Inc.

Tympanogen develops ear, nose, and throat devices and wound-healing therapies to improve treatment outcomes and decrease healthcare costs.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Richmond, VA, USA

total rounds

7

total raised

$2.29M
SinuSys Corp.

SinuSys Corp.

SinuSys Corporation develops medical devices to improve sinus health.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

total rounds

1
iTind

iTind

iTind offers a simple, non-surgical solution for Benign Prostatic Hyperplasia (BPH), improving men's quality of life.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Keywords

Health Care, Medical Device, Medical

Location

Or Akiva, Israel

total rounds

1
Lumendi

Lumendi

Lumendi develops medical technology for less invasive procedures and therapies.

Sector

Medical Equipment and Services

Subsector

Medical Equipment

Location

Westport, CT, USA
M&A Details
1

Acquired by

Entellus Medical

announced date

07.07.2017

price

$81M

Financials

Funding Rounds
4
3

Number of Funding Rounds

$71.5M

Money Raised

Their latest funding was raised on 15.03.2016. Their latest investor Correlation Ventures. Their latest round Series C

Date 
Funding Round 
Investors 
Money Raised 
Lead 
HealthQuest Capital

HealthQuest Capital

HealthQuest Capital is a private equity firm that invests in healthcare companies to optimize value, improve outcomes, and lower costs.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Financial Services, Venture Capital

Location

Menlo Park, CA, USA

total rounds

1

count Of Investments

43

count Of Exists

9
Kohlberg Kravis Roberts

Kohlberg Kravis Roberts

Kohlberg Kravis Roberts is a global investment firm that manages multiple alternative asset classes.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Finance, Venture Capital

Location

Hudson, NY 12534, USA

total rounds

2

total raised

$584.71M

count Of Investments

351

count Of Exists

65
Aperture Venture Partners

Aperture Venture Partners

Aperture Venture Partners is a venture capital group focused on investing in the healthcare and healthy living industries.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Venture Capital

Location

New York, NY, USA

count Of Investments

43

count Of Exists

12
Venrock

Venrock

Venrock partners with entrepreneurs to build disruptive, successful companies.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Venture Capital, Financial Services

Location

Palo Alto, CA, USA

count Of Investments

616

count Of Exists

216
Aisling Capital

Aisling Capital

Aisling Capital is a venture capital firm based in New York that focuses on investing in the pharmaceutical and biotechnology sectors.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Venture Capital, Financial Services

Location

New York, NY, USA

count Of Investments

103

count Of Exists

27
Co-Investors
Investors
7
5

Number of lead investors

7

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Series B, Series C
Correlation Ventures

Correlation Ventures

Correlation Ventures is a venture capital firm that finances early, seed, and later stage venture, and debt financing investments.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Keywords

Financial Services, Venture Capital, Finance

Location

San Diego, CA, USA

count Of Investments

294

count Of Exists

53
Aperture Venture Partners

Aperture Venture Partners

Aperture Venture Partners is a venture capital group focused on investing in the healthcare and healthy living industries.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Health Care, Venture Capital

Location

New York, NY, USA

count Of Investments

43

count Of Exists

12
Western Technology Investment

Western Technology Investment

Western Technology Investment is a venture capital firm that provides acquisition financing to revenue-generating technology companies.

Sector

Investment Banking and Brokerage Services

Subsector

Diversified Financial Services

Keywords

Financial Services, Venture Capital, Finance

Location

Portola Valley, CA, USA

count Of Investments

305

count Of Exists

103

People

Founders
2
Donald Gonzales
Donald Gonzales

Donald Gonzales

Dr. Gonzales belongs to a rare class of clinical entrepreneurs who successfully blend their clinical experience and business outlook to address unmet needs within the medical community. In 2004, he formed the first of several companies including Xorbent Technologies, Xorbent L.L.C. and Xorbent, Inc., that would eventually merge to become ENTrigue Surgical, Inc. ENTrigue Surgical was acquired by ArthroCare (ARTC) in 2013. He has also performed cutting-edge research at the Cardiovascular Research Center at Massachusetts General Hospital, Memorial Sloan Kettering, Strang Cancer Institute at Rockefeller University, and Cornell University. Dr. Gonzales has also had active clinical practices as a staff physician at Tulane University and in private practice in Beverly, MA. Currently, Dr. Gonzales is a founding partner for D3DC, a medical device development company. D3DC funds and manages early stage medical device companies. Dr. Gonzales graduated from Gordon College and Cornell University Medical College, then completed his residency in otolaryngology-head and neck surgery at Tulane University School of Medicine. He is also listed as an inventor on more than 50 patents and patent applications for devices and methods in ENT surgical applications.

current job

Stryker
Stryker

organization founded

2

Donald Gonzales

Duke Rohlen
Duke Rohlen

Duke Rohlen

Douglas S. Rohlen, also known as Duke, serves as Chief Executive Officer of Ajax Health LLC. Duke Rohlen serves as an Executive Chairman of EPIX Therapeutics, Inc., and has been its Chief Executive Officer. He is a Co-Founder of Ajax Vascular and serves as its Chief Executive Officer. He is a General Partner of D3DC, LLC. He has over two decades of experience in cardiovascular medical devices. He served as the Chief Executive Officer and President at Spirox, Inc. He was a Co-Founder of CV Ingenuity Corp., and served as its President and Chief Executive Officer. He was a Managing Partner of TauTona Group. He served as President of Fox Technologies. He served as Head of Investor Relations at Foxhollow Technologies Inc. He served as President of Strategic Operations at Foxhollow Technologies Inc. Duke Rohlen served as Vice President of Corporate Development and Investor Relations and as Director of Business Development since joining Foxhollow Technologies Inc., he served as President and Chief Executive Officer of Olive Hill Development, a land development company. He served as a Project Consultant at Massachusetts General Hospital. He served as Director of Business Development at LuMend Corporation, a privately-held company that develops chronic total occlusion products in the treatment of peripheral vascular disease which was acquired by Cordis Corporation. In 1999, he served as Entrepreneur in Residence at Alta Partners, a venture capital firm. He served as a Director of Entellus Medical, Inc., Duke Rohlen holds a B.A. in History from Stanford University and an MBA from Harvard Business School.

current job

Atriomx
Atriomx

count Of Investments

1

Duke Rohlen

Activity

Recent News
0